PNR vs SLS · P/E 18, rev $4.18B vs $1.62B cap
Pentair PLC (PNR) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
PNR currently screens at market cap $11.86B and trailing P/E 18.4. SLS currently screens at market cap $1.62B.
Not investment advice. Open the PNR and SLS stock pages for the full models.
Not investment advice.